<DOC>
	<DOCNO>NCT02395653</DOCNO>
	<brief_summary>The objective study evaluate safety clinical utility active , SSEC fentanyl 40 mcg management acute , postoperative pain pediatric patient .</brief_summary>
	<brief_title>Safety Clinical Utility Study SSEC Fentanyl 40 mcg Acute Post-op Pain Management Pediatric Patients</brief_title>
	<detailed_description>An open label evaluation safety clinical utility active , separated system enhance controller ( SSEC ) fentanyl 40 mcg management acute postoperative pain pediatric patient 12 less 18 year age .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Patients whose parent ( ) guardian ( ) have/has sign date informed consent form patient participate study , patient provide write assent participate study Male female inpatient , age 12 &lt; 18 year age inclusive day surgery Patients capable understand cooperating requirement study , include able report pain intensity use 11point NRS operate SSEC American Society Anesthesiologists ( ASA ) physical status I , II III Body weight least 40.0 kg Postoperative patient undergone general regional anaesthesia abdominal , pelvic/genitourinary , orthopaedic , thoracic surgery Postoperative patient observe recovery expect remain hospitalized pain require parenteral opioids ( i.e. , IV PCA ) next 24 hour longer Patients awake breathe spontaneously respiratory rate 14 18 breath per minute , SpO2 ≥ 93 % ( without supplemental oxygen ) , able answer question follow command Patients observed recovery , awake , able answer question follow command , comfortable least 30 minute , pain intensity score ≤ 4 ( numeric rating scale 0 10 ) , without titration comfort IV opioids Patients undergone surgery airway , head , neck Patients receive extendedrelease opioid within 48 hour prior Hour 0 expect postoperative analgesia supply continuous regional technique patientcontrolled epidural analgesia Patients history allergy hypersensitivity fentanyl , skin adhesive , and/or cetylpyridinium chloride Patients expect require intensive care likely require additional surgical procedure within 36 hour Patients receive intraoperative and/or postoperative administration opioids morphine , hydromorphone , fentanyl , sufentanil , alfentanil . Exception : If medical contraindication , meperidine ( pethidine ) 0.5 mg/kg IV permit recovery shivering Patients require airway support ( nasal oropharyngeal airway intubation , laryngeal mask airway [ LMA ] ) time final baseline assessment ( i.e. , time IONSYS application [ Hour 0 ] ) Patients know suspected opioid tolerant , history opioid dependence within 3 month start study , know hav eused illicit drug alcohol within 14 day start study Patients active generalized skin disorder active local skin disease preclude SSEC application chest upper arm Patients coexist major medical condition likely interfere study procedure include , limited , psychiatric condition , chronic depression , suicidal ideation , autism Positive pregnancy test female</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Pediatric</keyword>
	<keyword>Postoperative</keyword>
	<keyword>Pain Management</keyword>
</DOC>